73 related articles for article (PubMed ID: 23603030)
1. Enhanced interaction among ErbB4, PSD-95 and NMDAR by chronic MK-801 treatment is associated with behavioral abnormalities.
Li JT; Feng Y; Su YA; Wang XD; Si TM
Pharmacol Biochem Behav; 2013 Jul; 108():44-53. PubMed ID: 23603030
[TBL] [Abstract][Full Text] [Related]
2. Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life.
du Bois TM; Newell KA; Huang XF
Eur Neuropsychopharmacol; 2012 May; 22(5):356-63. PubMed ID: 21962913
[TBL] [Abstract][Full Text] [Related]
3. Alterations in long-term seizure susceptibility and the complex of PSD-95 with NMDA receptor from animals previously exposed to perinatal hypoxia.
Chen WF; Chang H; Huang LT; Lai MC; Yang CH; Wan TH; Yang SN
Epilepsia; 2006 Feb; 47(2):288-96. PubMed ID: 16499752
[TBL] [Abstract][Full Text] [Related]
4. Prenatal morphine alters the synaptic complex of postsynaptic density 95 with N-methyl-D-aspartate receptor subunit in hippocampal CA1 subregion of rat offspring leading to long-term cognitive deficits.
Lin CS; Tao PL; Jong YJ; Chen WF; Yang CH; Huang LT; Chao CF; Yang SN
Neuroscience; 2009 Feb; 158(4):1326-37. PubMed ID: 19041927
[TBL] [Abstract][Full Text] [Related]
5. Amitriptyline attenuates astrocyte activation and morphine tolerance in rats: role of the PSD-95/NR1/nNOS/PKCγ signaling pathway.
Huang YN; Tsai RY; Lin SL; Chien CC; Cherng CH; Wu CT; Yeh CC; Wong CS
Behav Brain Res; 2012 Apr; 229(2):401-11. PubMed ID: 22309983
[TBL] [Abstract][Full Text] [Related]
6. UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: comparison with the NMDA receptor antagonist MK-801.
Andreasen JT; Bach A; Gynther M; Nasser A; Mogensen J; Strømgaard K; Pickering DS
Neuropharmacology; 2013 Apr; 67():193-200. PubMed ID: 23178182
[TBL] [Abstract][Full Text] [Related]
7. Long-term behavioral and NMDA receptor effects of young-adult corticosterone treatment in BDNF heterozygous mice.
Klug M; Hill RA; Choy KH; Kyrios M; Hannan AJ; van den Buuse M
Neurobiol Dis; 2012 Jun; 46(3):722-31. PubMed ID: 22426399
[TBL] [Abstract][Full Text] [Related]
8. N-methyl-D-aspartate receptor-dependent long-term potentiation in CA1 region affects synaptic expression of glutamate receptor subunits and associated proteins in the whole hippocampus.
Zhong WX; Dong ZF; Tian M; Cao J; Xu L; Luo JH
Neuroscience; 2006 Sep; 141(3):1399-413. PubMed ID: 16766131
[TBL] [Abstract][Full Text] [Related]
9. N-methyl-D-aspartate receptor responses are differentially modulated by noncompetitive receptor antagonists and ethanol in inbred long-sleep and short-sleep mice: behavior and electrophysiology.
Hanania T; Negri CA; Dunwiddie TV; Zahniser NR
Alcohol Clin Exp Res; 2000 Dec; 24(12):1750-8. PubMed ID: 11141032
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal interactions between MK-801, sleep deprivation and recovery in modulating rat behaviour.
Dubiela FP; Messias MF; Moreira KD; Zanlorenci LH; Grassl C; Filho RF; Nobrega JN; Tufik S; Hipólide DC
Behav Brain Res; 2011 Jan; 216(1):180-5. PubMed ID: 20678528
[TBL] [Abstract][Full Text] [Related]
11. Impaired working memory by repeated neonatal MK-801 treatment is ameliorated by galantamine in adult rats.
Su YA; Huang RH; Wang XD; Li JT; Si TM
Eur J Pharmacol; 2014 Feb; 725():32-9. PubMed ID: 24440172
[TBL] [Abstract][Full Text] [Related]
12. Alterations of NR2B and PSD-95 expression in hippocampus of kainic acid-exposed rats with behavioural deficits.
Sun QJ; Duan RS; Wang AH; Shang W; Zhang T; Zhang XQ; Chi ZF
Behav Brain Res; 2009 Aug; 201(2):292-9. PubMed ID: 19428647
[TBL] [Abstract][Full Text] [Related]
13. Schizophrenia: more evidence for less glutamate.
Morrison PD; Pilowsky LS
Expert Rev Neurother; 2007 Jan; 7(1):29-31. PubMed ID: 17187494
[TBL] [Abstract][Full Text] [Related]
14. MK-801 suppresses muricidal behavior but not locomotion in olfactory bulbectomized rats: involvement of NMDA receptors.
Ho YJ; Chen KH; Tai MY; Tsai YF
Pharmacol Biochem Behav; 2004 Mar; 77(3):641-6. PubMed ID: 15006477
[TBL] [Abstract][Full Text] [Related]
15. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
Zajaczkowski W; Czyrak A; Wedzony K
Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
Seillier A; Giuffrida A
Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985
[TBL] [Abstract][Full Text] [Related]
17. Neonatal exposure to MK-801, an N-methyl-D-aspartate receptor antagonist, enhances methamphetamine-induced locomotion and disrupts sensorimotor gating in pre- and postpubertal rats.
Uehara T; Sumiyoshi T; Seo T; Matsuoka T; Itoh H; Suzuki M; Kurachi M
Brain Res; 2010 Sep; 1352():223-30. PubMed ID: 20633540
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antinociceptive effects of N-methyl-D-aspartate receptor antagonist and electroacupuncture in the complete Freund's adjuvant-induced pain model.
Jang JY; Kim HN; Koo ST; Shin HK; Choe ES; Choi BT
Int J Mol Med; 2011 Oct; 28(4):669-75. PubMed ID: 21687934
[TBL] [Abstract][Full Text] [Related]
19. Expressions of neuregulin 1beta and ErbB4 in prefrontal cortex and hippocampus of a rat schizophrenia model induced by chronic MK-801 administration.
Feng Y; Wang XD; Guo CM; Yang Y; Li JT; Su YA; Si TM
J Biomed Biotechnol; 2010; 2010():859516. PubMed ID: 20467458
[TBL] [Abstract][Full Text] [Related]
20. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
